Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age at diagnosis and histology are limited. Such data can assist genetic counseling and help elucidate etiologic differences among various histologic types of ovarian malignancies. By using the Swedish Family-Cancer Database, we calculated relative risks (RRs) for detailed family histories using a two-way comparison, which implied e.g. estimation of RRs for overall ovarian cancer when family history was histology-specific ovarian cancer, and conversely, RRs for histology-specific ovarian cancer when family history was overall ovarian cancer. In families of only mother, only sisters or both mother and sisters diagnosed with ovarian cancer, cancer r...
Large amounts of germline sequencing data have recently become available and we sought to compare th...
Background BRCA1 or BRCA2 mutations confer increased risks of breast and ovarian cancer, but risks h...
Simple Summary Familial cancer can be defined through the occurrence of the same cancer in two or mo...
Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age a...
Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age a...
Familial risk of ovarian cancer is well-established but whether ovarian cancer clusters with other c...
BACKGROUND: Practically all data on familial risk in ovarian and other cancers are based on incident...
Background: Borderline ovarian tumors (BOTs) are a subgroup of ovarian malignancies with low maligna...
A cohort of offspring of mothers with breast or ovarian cancer diagnosed in 1958–1993 was establishe...
The aim of this study was to examine the relationship between history of cancer in first-degree rela...
Familial risks for cancer are important for clinical counseling and understanding cancer etiology. M...
This thesis reports on epidemiological studies on family related cancer in Sweden. The Family-Cancer...
IntroductionThe long-term risk of cancer among first-degree relatives of ovarian cancer patients, es...
Familial risk of ovarian cancer in daughters by proband type and age of diagnosis.</p
Background: With improving survival in ovarian cancer, second primary cancers (SPCs) and their etiol...
Large amounts of germline sequencing data have recently become available and we sought to compare th...
Background BRCA1 or BRCA2 mutations confer increased risks of breast and ovarian cancer, but risks h...
Simple Summary Familial cancer can be defined through the occurrence of the same cancer in two or mo...
Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age a...
Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age a...
Familial risk of ovarian cancer is well-established but whether ovarian cancer clusters with other c...
BACKGROUND: Practically all data on familial risk in ovarian and other cancers are based on incident...
Background: Borderline ovarian tumors (BOTs) are a subgroup of ovarian malignancies with low maligna...
A cohort of offspring of mothers with breast or ovarian cancer diagnosed in 1958–1993 was establishe...
The aim of this study was to examine the relationship between history of cancer in first-degree rela...
Familial risks for cancer are important for clinical counseling and understanding cancer etiology. M...
This thesis reports on epidemiological studies on family related cancer in Sweden. The Family-Cancer...
IntroductionThe long-term risk of cancer among first-degree relatives of ovarian cancer patients, es...
Familial risk of ovarian cancer in daughters by proband type and age of diagnosis.</p
Background: With improving survival in ovarian cancer, second primary cancers (SPCs) and their etiol...
Large amounts of germline sequencing data have recently become available and we sought to compare th...
Background BRCA1 or BRCA2 mutations confer increased risks of breast and ovarian cancer, but risks h...
Simple Summary Familial cancer can be defined through the occurrence of the same cancer in two or mo...